CTKB News and Press, Cytek Biosciences Inc. From 08/07/25

2025-08-07 04:26:40 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytek Biosciences Historical earnings data ...

2025-08-06 17:33:03 ET More on Cytek Biosciences Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytek Biosciences Historical earnings data for Cytek Biosciences Financial information for Cytek Bioscience...

FREMONT, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2025. Second Q...

Sera Prognostics Inc. (SERA) is expected to report $-0.21 for Q2 2025 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.51 for Q2 2025 Context Therapeutics Inc. (CNTX) is expected to report $-0.06 for Q2 2025 Genco Shipping & Trading ...

Cytek Biosciences Inc. (CTKB) is expected to report $-0.07 for Q2 2025

FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025. The company’...

FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow cytometer that improves on...

FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46 th Annual Global Healthcare Conference in Miami Beach, FL. Cytek manageme...

2025-05-11 20:30:33 ET Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Conference Call May 08, 2025, 04:30 PM ET Company Participants Paul Goodson - IR Wenbin Jiang - CEO William McCombe - CFO Conference Call Participants David Westenberg - Piper Sand...

2025-05-08 16:57:11 ET More on Cytek Biosciences Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued? Cytek Biosciences reports Q4 results and provides 2025 outlook Seeking Alpha’s Quant Rating on Cytek Biosciences ...